The Temporal Hyper-Morbidity of Asthma and Attention Deficit Disorder: Implications for Interpretation Based on Comparison of Prospective and Cross-Sectional Population Samples
Pang Hua Chai, Sam Chang, David Cawthorpe
Psychiatry Investig. 2021;18(2):166-171.   Published online 2021 Feb 22     DOI:
Evaluation of the frequency of attention deficit hyperactivity disorder in patients with asthma
Matineh Nirouei, Mona Kouchekali, Homa Sadri, Mostafa Qorbani, Hadi Montazerlotfelahi, Narges Eslami, Marzieh Tavakol
Clinical and Molecular Allergy.2023;[Epub]     CrossRef
Population-based affective-disorder-related biomedical/biophysical multi-hyper-morbidity across the lifespan: A 16-year population study
David R L Cawthorpe, Dan Cohen
World Journal of Psychiatry.2023; 13(7): 423.     CrossRef
Comorbidity of asthma in patients with attention-deficit/hyperactivity disorder (ADHD) aged 4–12 years in Iran: a cross-sectional study
Arezou Kiani, Hamidreza Houshmand, Gholamreza Houshmand, Yasin Mohammadi
Annals of Medicine & Surgery.2023; 85(6): 2568.     CrossRef
Two meta-analyses of the association between atopic diseases and core symptoms of attention deficit hyperactivity disorder
Yu-Chieh Chuang, Ching-Yun Wang, Wei-Lieh Huang, Liang-Jen Wang, Ho-Chang Kuo, Yang-Ching Chen, Yu-Jui Huang
Scientific Reports.2022;[Epub]     CrossRef
Paediatric asthma and non‐allergic comorbidities: A review of current risk and proposed mechanisms
Bronwyn K. Brew, Emma Caffrey Osvald, Tong Gong, Anna M. Hedman, Kirsten Holmberg, Henrik Larsson, Jonas F. Ludvigsson, Mwenya Mubanga, Awad I. Smew, Catarina Almqvist
Clinical & Experimental Allergy.2022; 52(9): 1035.     CrossRef
Microbiome First Medicine in Health and Safety
Rodney R. Dietert
Biomedicines.2021; 9(9): 1099.     CrossRef